Johnson & Johnson applies for EUA of its single-dose COVID-19 vaccine in India
The Hindu
‘This is an important milestone that paves the way for bringing the company's single-dose COVID-19 vaccine to the people of India, and the rest of the world, through a collaboration with Biological E Limited’
Global healthcare major Johnson & Johnson on August 6 said it has applied for Emergency Use Authorization (EUA) of its single-dose COVID-19 vaccine in India. Earlier on August 2, the company had said that it remained committed to bringing its single-dose COVID-19 vaccine to India and looks forward to ongoing discussions with the Indian government. "On August 5, 2021 Johnson & Johnson Pvt Ltd applied for EUA of its single-dose COVID-19 vaccine to the government of India," a Johnson & Johnson India spokesperson said in a statement.More Related News